MAPT and Alzheimer disease: While it is debated whether early abnormal tau is a fundamental component of Alzheimer’s disease [90,91], the early rise in tau is ultimately toxic to neurons and synapses, in both animals [76,92] and humans [93–95], and is a prominent component of early pathological aging.